Letter to the Editor: We read with much interest the article "Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China" by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: